- Home
- CNDT vs ABUS Comparison
CNDT vs ABUS Comparison
Compare CNDT & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNDT
- ABUS
- Stock Information
- Founded
- CNDT 2016
- ABUS N/A
- Country
- CNDT United States
- ABUS United States
- Employees
- CNDT N/A
- ABUS N/A
- Industry
- CNDT Business Services
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- CNDT Consumer Discretionary
- ABUS Health Care
- Exchange
- CNDT Nasdaq
- ABUS Nasdaq
- Market Cap
- CNDT 537.3M
- ABUS 636.2M
- IPO Year
- CNDT N/A
- ABUS N/A
- Fundamental
- Price
- CNDT $3.04
- ABUS $3.37
- Analyst Decision
- CNDT Buy
- ABUS Strong Buy
- Analyst Count
- CNDT 1
- ABUS 4
- Target Price
- CNDT $9.00
- ABUS $5.50
- AVG Volume (30 Days)
- CNDT 1.0M
- ABUS 1.0M
- Earning Date
- CNDT 04-30-2025
- ABUS 05-01-2025
- Dividend Yield
- CNDT N/A
- ABUS N/A
- EPS Growth
- CNDT N/A
- ABUS N/A
- EPS
- CNDT 2.23
- ABUS N/A
- Revenue
- CNDT $3,356,000,000.00
- ABUS $6,742,000.00
- Revenue This Year
- CNDT N/A
- ABUS N/A
- Revenue Next Year
- CNDT $2.19
- ABUS N/A
- P/E Ratio
- CNDT $1.39
- ABUS N/A
- Revenue Growth
- CNDT N/A
- ABUS N/A
- 52 Week Low
- CNDT $2.96
- ABUS $2.30
- 52 Week High
- CNDT $4.90
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- CNDT 26.76
- ABUS 53.91
- Support Level
- CNDT $3.25
- ABUS $3.32
- Resistance Level
- CNDT $3.40
- ABUS $3.55
- Average True Range (ATR)
- CNDT 0.14
- ABUS 0.19
- MACD
- CNDT -0.05
- ABUS -0.02
- Stochastic Oscillator
- CNDT 11.35
- ABUS 58.82
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.